⌘K

Login Start Free

Home/Filings/4/0000899243-22-025515

4//SEC Filing

Kender Richard N 4

Accession 0000899243-22-025515

CIK 0001609809other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 7:23 PM ET

Size

4.6 KB

Accession

0000899243-22-025515

Insider Transaction Report

Form 4

Period: 2022-07-05

Seres Therapeutics, Inc.MCRB

Kender Richard N

Director

Transactions

Award
COMMON STOCK
2022-07-05$3.15/sh+63,492$200,000→ 63,492 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1

filerCIK 0001381205

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 7:23 PM ET
Size: 4.6 KB

View on SEC.gov